EuBiologics Co., Ltd. (206650.KQ)
KRW 13100.0
(0.08%)
KRW 13100.0
(0.08%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -381.00 KRW | -1161.31% |
| 2022 | -30.19 KRW | 96.12% |
| 2021 | -777.82 KRW | 63.76% |
| 2020 | -2146.27 KRW | -6534.53% |
| 2019 | -32.35 KRW | -122.18% |
| 2018 | 145.87 KRW | 177.52% |
| 2017 | -188.18 KRW | 51.23% |
| 2016 | -385.87 KRW | -241.96% |
| 2015 | -112.84 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -99.17 KRW | 71.55% |
| 2024 Q2 | -43.59 KRW | 55.63% |
| 2023 Q3 | -85.10 KRW | -252.18% |
| 2023 Q2 | 55.92 KRW | 2021.65% |
| 2023 FY | - KRW | -1161.31% |
| 2023 Q1 | -2.91 KRW | 96.68% |
| 2023 Q4 | -348.63 KRW | -309.67% |
| 2022 Q1 | 3.26 KRW | 268.04% |
| 2022 FY | - KRW | 96.12% |
| 2022 Q3 | 6.85 KRW | -85.53% |
| 2022 Q2 | 47.33 KRW | 1351.84% |
| 2022 Q4 | -87.57 KRW | -1378.39% |
| 2021 Q3 | 57.26 KRW | 107.56% |
| 2021 Q1 | -85.73 KRW | 0.0% |
| 2021 FY | - KRW | 63.76% |
| 2021 Q2 | -757.00 KRW | -783.0% |
| 2021 Q4 | -1.94 KRW | -103.39% |
| 2020 FY | - KRW | -6534.53% |
| 2019 FY | - KRW | -122.18% |
| 2018 FY | - KRW | 177.52% |
| 2017 FY | - KRW | 51.23% |
| 2016 FY | - KRW | -241.96% |
| 2015 FY | - KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | -666.05 KRW | 42.797% |
| CMG Pharmaceutical Co., Ltd. | 46.00 KRW | 928.261% |
| Celltrion Pharm, Inc. | 539.00 KRW | 170.686% |
| Huons Global Co., Ltd. | 3133.85 KRW | 112.158% |
| DongKook Pharmaceutical Co., Ltd. | 1073.13 KRW | 135.504% |
| Enzychem Lifesciences Corporation | -109.81 KRW | -246.963% |
| Humedix Co., Ltd. | 2512.11 KRW | 115.167% |
| Boditech Med Inc. | 1181.00 KRW | 132.261% |
| FutureChem Co.,Ltd | -303.61 KRW | -25.49% |
| Huons Co., Ltd. | 4261.00 KRW | 108.942% |
| BNC Korea Co., Ltd. | 388.00 KRW | 198.196% |
| AptaBio Therapeutics Inc. | -540.91 KRW | 29.563% |